ClinicalTrials.gg
RecruitingNCT05963152Updated Sep 8, 2023

Resistance Exercise and Cognition in People With Type 1 Diabetes

An interventional study of Habitual Physical Activity and Morning Exercise in type1diabetes, sponsored by Dasman Diabetes Institute. Recruiting at 1 site in Kuwait. Open to participants aged 21 Years to 60 Years. Per ClinicalTrials.gov, last updated 2023-09-08.

Sponsored by Dasman Diabetes Institute · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Primary completion was expected by Aug 2024, 2 years 3 months ago, but the record still lists the study as recruiting.
  • Started Jul 2023; still recruiting 3 years 3 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
54
Allocation
Randomized
Ages
21 Years to 60 Years
Sex
All
01

Study summary

The aim of the current study is to determine the effects of resistance exercise on performance of the Paced Auditory Serial Addition Test and the Colour Trails Test.

02

Conditions studied

  • type1diabetes

Browse trials for

Keywords

  • exercise
  • cognition
03

In context

Motor Activity

9,798 studies on the registry are indexed under Motor Activity; 1,910 are open to participants now.

This study's planned enrollment of 54 is close to the median of 60 across 8,388 interventional studies indexed under Motor Activity.

Browse Motor Activity studies →

Lead sponsor

Dasman Diabetes Institute is the lead sponsor of 31 studies on the registry; 14 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Physician confirmed type 1 diabetes for at least 1 year
  • Stable insulin therapy for 3 months prior to the study

Exclusion criteria

Exclusion Criteria:

  • of 45 or higher
  • BP of 160/100mmHg or higher
  • autonomic neuropathy
  • severe proliferative retinopathy
  • joint or limb injuries preventing weight-bearing activity
  • autonomic neuropathy
  • severe proliferative retinopathy
  • any other medical condition that prevents participants from exercising safely.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
54 participants (estimated)

Study arms

  • Placebo comparator
    Control

    Habitual Physical Activity

    Behavioral: Habitual Physical Activity

  • Experimental
    Morning exercise

    Exercise training between 6-10am

    Behavioral: Morning Exercise

  • Experimental
    Afternoon exercise

    Exercise training between 4-8pm

    Behavioral: Afternoon Exercise

Interventions

  • BehavioralHabitual Physical Activity

    Participants will be asked to maintain their normal activity levels

  • BehavioralMorning Exercise

    Between 6-10am participants will attend the gym and perform 10 min of warm up exercise, 3 sets of 7 resistance exercises ( leg press, calf press, leg curl, chest press, lateral raise, seated row and plank)

  • BehavioralAfternoon Exercise

    Between 4-8pm participants will attend the gym and perform 10 min of warm up exercise, 3 sets of 7 resistance exercises ( leg press, calf press, leg curl, chest press, lateral raise, seated row and plank)

06

What researchers measure

Primary outcomes

  1. Chronic change in Paced Auditory Serial Addition Test (PASAT) score

    Measured using the standardised Paced Auditory Serial Addition Test (PASAT) score ranging from 0-60 with a higher score meaning a better outcome

    Time frame: Change from baseline to 12 weeks

  2. Chronic change in Colour Trails Test score

    Measured using the standardised Colour Trails Test, with score based on completion time (0-240s), number of errors, error type, and number of prompts with a shorter completion time and lower number of errors and prompts indicating a better outcome

    Time frame: Change from baseline to 12 weeks

Secondary outcomes

  1. Baseline acute change in Paced Auditory Serial Addition Test (PASAT) score

    Measured using the standardised Paced Auditory Serial Addition Test (PASAT) during the first exercise session, score ranging from 0-60 with a higher score meaning a better outcome

    Time frame: Change from before (0 hour) to 1 hour post exercise during week 1

  2. 12 week acute change in Paced Auditory Serial Addition Test (PASAT) score

    Measured using the standardised Paced Auditory Serial Addition Test (PASAT) during the last exercise session, score ranging from 0-60 with a higher score meaning a better outcome

    Time frame: Change from before (0 hour) to 1 hour post exercise during week 12

  3. Baseline acute change in Colour Trails Test score

    Measured using the standardised Colour Trails Test during the first exercise session, with score based on completion time (0-240s), number of errors, error type, and number of prompts with a shorter completion time and lower number of errors and prompts indicating a better outcome

    Time frame: Change from before (0 hour) to 1 hour post exercise during week 1

  4. 12 week acute change in Colour Trails Test score

    Measured using the standardised Colour Trails Test during the last exercise session, with score based on completion time (0-240s), number of errors, error type, and number of prompts with a shorter completion time and lower number of errors and prompts indicating a better outcome

    Time frame: Change from before (0 hour) to 1 hour post exercise during week 12

07

Study locations

1 of 1 sites recruiting
  • Dasman Diabetes Institute
    Kuwait City, 15462, Kuwait
    Recruiting
    • Ebaa AlOZairi · Contact
    • Ebaa AlOzairi · Principal investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 8, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05963152
Lead sponsor
Dasman Diabetes Institute
Responsible party
Dr. Ebaa Al Ozairi (Chief Medical Officer, Dasman Diabetes Institute) — Principal investigator
First posted
Jul 27, 2023
Start date
Jul 20, 2023
Primary completion
Aug 1, 2024 (estimated)
Completion
Aug 1, 2024 (estimated)
Last update
Sep 8, 2023

Study contacts

Ebaa AlOzairi
Contact
ebaa.alozairi@dasmaninstitute.rog
+965 22242999 ext. 3111

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion